Comparative reference-controlled investigation of bleeding pattern under treatment with a vaginal delivery system (EVE112) containing a fixed dose combination of etonogestrel and ethinylestradiol A multi-centre, multi-dose, open-label, parallel-group study in healthy females aged 18-40 years and at risk for becoming pregnant

Trial Profile

Comparative reference-controlled investigation of bleeding pattern under treatment with a vaginal delivery system (EVE112) containing a fixed dose combination of etonogestrel and ethinylestradiol A multi-centre, multi-dose, open-label, parallel-group study in healthy females aged 18-40 years and at risk for becoming pregnant

Recruiting
Phase of Trial: Phase III

Latest Information Update: 03 Apr 2017

At a glance

  • Drugs Ethinylestradiol/etonogestrel (Primary)
  • Indications Pregnancy
  • Focus Adverse reactions
  • Sponsors Evestra
  • Most Recent Events

    • 06 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top